Revanesse hosts annual masterclass
Dermal filler brand Revanesse, owned by PROLLENIUM, hosted the Revanesse Redefine Conference 2026. The conference welcomed more than 130 aesthetic practitioners to London’s Ham Yard Hotel on February 2, 2026,
Dermal filler brand Revanesse, owned by PROLLENIUM, hosted the Revanesse Redefine Conference 2026. The conference welcomed more than 130 aesthetic practitioners to London’s Ham Yard Hotel on February 2, 2026,
Dr Amy Watson offers a glimpse into her daily routine and her role working with Alma and Revanesse A typical working day… As any parent with young children will know, days start very early – and for me it is …
Injectable company Prollenium, distributed in the UK by Alma, held the first Revanesse Redefine Conference on March 3 at The Ham Yard Hotel in London. Revanesse shares that the event
Dermal filler range Revanesse has shared that its inaugural Redefine Conference will take place on March 3 at the Ham Yard Hotel in London. Revanesse explains that the conference aims
Dermal filler range Revanesse has announced details for the first Inner Circle Meeting on January 27 in Yorkshire. The company shares that the meeting will involve an opportunity for networking
Nurse prescriber Natali Kelly shares how Revanesse® is the perfect partner for her natural-looking artistry. While reports have said dermal filler treatments are reducing by 33% year on year,1 those in the know believe in the rise of ‘undetectable dermal …
Aesthetic manufacturer Prollenium Medical Technologies has unveiled its latest dermal filler to the Revanesse range – Revise+. According to the company, Revise+ is designed to address delicate areas like the
World-renowned plastic surgeon and aesthetic practitioner Dr Arthur Swift has announced a training day in London this month, in collaboration with Prollenium.
As Prollenium acquires aesthetic leaders SoftFil CEO Dr Sandrine Sebban explores what this means for the industry
Dr Johanna Ward outlines why she decided to join the Spherical Revolution with Prollenium and enjoys using the REVANESSE portfolio